1
|
Sekiguchi Y, Tsutsumi H, Gomyo A, Kudo M, Maseki N, Iizaki Y, Kawamura M, Kobayashi K, Nitta H, Noguchi M, Wakita S, Yamaguchi H, Kobayashi H. A Case of Relapsed/Refractory CD56-Positive Acute Promyelocytic Leukemia, in Which Complete Molecular Remission Was Achieved Following Combination Therapy with Venetoclax and Azacitidine. Gan To Kagaku Ryoho 2024; 51:291-297. [PMID: 38494811] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/19/2024]
Abstract
An 84-year-old woman was diagnosed as having acute promyelocytic leukemia(APL)in July Year X-3. The test for promyelocytic leukemia- retinoic acid receptor alpha(PML-RARA)mRNA was positive, while that for CD56 was negative. Since her white blood cell( WBC) count was <3,000/μL, with a count of APL cells of <1,000/μL, she was started on monotherapy with all-trans retinoic acid(ATRA). In September Year X-3, complete hematological remission(CHR)was confirmed. she refused to provide consent for receiving consolidation therapy. In February Year X-2, hematological relapse occurred. She was started on re-induction therapy with arsenite(ATO), and in June Year X-2, complete molecular remission(CMR)was achieved. She was started on post-remission therapy with ATO. In August Year X-1, she developed molecular relapse and was started on tamibarotene(Am80). In October Year X-1, hematological relapse was detected, and the test for CD56 was positive. She was started on combined venetoclax(VEN)+azacitidine(AZA)(VEN+AZA). After completion of 1 course of treatment, CMR was achieved, but she developed hematological relapse after 5 courses of treatment. She died of gastrointestinal hemorrhage. This is considered a valuable case for accumulating information on the treatment of CD56-positive APL resistant to ATRA and ATO.
Collapse
|
2
|
Kobayashi H, Tsutsumi H, Misaki Y, Maekawa T, Inoshita N, Kawamura M, Maseki N. Gilteritinib Monotherapy as a Transplant Bridging Option for a Patient with FLT3-Mutated Acute Promyelocytic Leukemia Who Developed a Second Relapse after All-Trans Retinoic Acid + Chemotherapy, Arsenic Trioxide, and High-Dose Cytarabine Therapy. Case Rep Hematol 2023; 2023:8568587. [PMID: 38124780 PMCID: PMC10732830 DOI: 10.1155/2023/8568587] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2023] [Revised: 11/17/2023] [Accepted: 11/29/2023] [Indexed: 12/23/2023] Open
Abstract
We report a case of FLT3-mutated APL who developed disease relapse despite all-trans retinoic acid (ATRA) + chemotherapy, and re-induction chemotherapy with arsenic trioxide (ATO) and high-dose (HD) cytarabine (Ara-C) therapy failed to yield complete remission. Because the leukemic cells were resistant to all the aforementioned therapies, we started the patient on monotherapy with gilteritinib, a selective FLT3-inhibitor, as an alternative re-induction treatment option rather than further intensive chemotherapy. The patient showed complete hematologic remission in response to this therapy. This case serves as supporting evidence for the use of single-agent therapy with gilteritinib as a bridge to transplantation in patients with refractory FLT3-mutated APL.
Collapse
Affiliation(s)
| | - Hiroki Tsutsumi
- Department of Hematology, Saitama Cancer Center, Saitama, Japan
| | - Yukiko Misaki
- Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan
| | - Takashi Maekawa
- Department of Pathology, Saitama Cancer Center, Saitama, Japan
| | - Naoko Inoshita
- Department of Pathology, Saitama Cancer Center, Saitama, Japan
- Department of Pathology, Moriyama Memorial Hospital, Tokyo, Japan
| | - Machiko Kawamura
- Department of Hematology, Saitama Cancer Center, Saitama, Japan
- Department of Clinical Laboratory Medicine, Saitama Cancer Center, Saitama, Japan
| | - Nobuo Maseki
- Department of Hematology, Saitama Cancer Center, Saitama, Japan
| |
Collapse
|
3
|
Sekiguchi Y, Nishimura Y, Kanda H, Kawamura M, Kobayashi K, Mitani K, Kurashina R, Ikeda R, Inoue M, Matsuoka Y, Kageyama Y, Akaba Y, Kobayashi H. A Case of Immune Thrombocytopenia Occurring after Radiotherapy plus Atezolizumab Treatment for Bladder Cancer. Gan To Kagaku Ryoho 2023; 50:985-992. [PMID: 37800294] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/07/2023]
Abstract
An 84-year-old female developed gross hematuria. She was diagnosed as urinary bladder carcinoma. She was initiated on concurrent atezolizumab plus radiation(a phase Ⅱ clinical trial)(jRCT2031180060). After 8 cycles of atezolizumab, complete response was confirmed. Maintenance atezolizumab treatment was started. Platelet(Plt)count decreased, there was no rechallenge with atezolizumab. Bone marrow examination revealed normal. Plt count recovered. Plt count decreased again. The serum levels of interleukin-6(IL-6)were elevated. She was diagnosed as having immune thrombocytopenia. She was started on treatment with prednisolone(PSL)at dose of 20 mg/day. Plt count was increased.
Collapse
|
4
|
Ito H, Uragami N, Miyazaki T, Shimamura Y, Ikeda H, Nishikawa Y, Onimaru M, Matsuo K, Isozaki M, Yang W, Issha K, Kimura S, Kawamura M, Yokoyama N, Kushima M, Inoue H. Determination of esophageal squamous cell carcinoma and gastric adenocarcinoma on raw tissue using Raman spectroscopy. World J Gastroenterol 2023; 29:3145-3156. [PMID: 37346148 PMCID: PMC10280800 DOI: 10.3748/wjg.v29.i20.3145] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/12/2022] [Revised: 04/10/2023] [Accepted: 04/27/2023] [Indexed: 05/26/2023] Open
Abstract
BACKGROUND Cancer detection is a global research focus, and novel, rapid, and label-free techniques are being developed for routine clinical practice. This has led to the development of new tools and techniques from the bench side to routine clinical practice. In this study, we present a method that uses Raman spectroscopy (RS) to detect cancer in unstained formalin-fixed, resected specimens of the esophagus and stomach. Our method can record a clear Raman-scattered light spectrum in these specimens, confirming that the Raman-scattered light spectrum changes because of the histological differences in the mucosal tissue.
AIM To evaluate the use of Raman-scattered light spectrum for detecting endoscop-ically resected specimens of esophageal squamous cell carcinoma (SCC) and gastric adenocarcinoma (AC).
METHODS We created a Raman device that is suitable for observing living tissues, and attempted to acquire Raman-scattered light spectra in endoscopically resected specimens of six esophageal tissues and 12 gastric tissues. We evaluated formalin-fixed tissues using this technique and captured shifts at multiple locations based on feasibility, ranging from six to 19 locations 200 microns apart in the vertical and horizontal directions. Furthermore, a correlation between the obtained Raman scattered light spectra and histopathological diagnosis was performed.
RESULTS We successfully obtained Raman scattered light spectra from all six esophageal and 12 gastric specimens. After data capture, the tissue specimens were sent for histopathological analysis for further processing because RS is a label-free methodology that does not cause tissue destruction or alterations. Based on data analysis of molecular-level substrates, we established cut-off values for the diagnosis of esophageal SCC and gastric AC. By analyzing specific Raman shifts, we developed an algorithm to identify the range of esophageal SCC and gastric AC with an accuracy close to that of histopathological diagnoses.
CONCLUSION Our technique provides qualitative information for real-time morphological diagnosis. However, further in vivo evaluations require an excitation light source with low human toxicity and large amounts of data for validation.
Collapse
Affiliation(s)
- Hiroaki Ito
- Digestive Disease Center, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan
| | - Naoyuki Uragami
- Digestive Disease Center, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan
| | | | - Yuto Shimamura
- Digestive Disease Center, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan
| | - Haruo Ikeda
- Digestive Disease Center, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan
| | - Yohei Nishikawa
- Digestive Disease Center, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan
| | - Manabu Onimaru
- Digestive Disease Center, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan
| | - Kai Matsuo
- Digestive Disease Center, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan
| | - Masayuki Isozaki
- Digestive Disease Center, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan
| | - William Yang
- Bay Spec Inc., San Jose, CA 95131, United States
| | - Kenji Issha
- Fuji Technical Research Inc., Yokohama 220-6215, Japan
| | - Satoshi Kimura
- Department of Laboratory Medicine and Central Clinical Laboratory, Showa University Northern Yokohama Hospital, Yokohama 224-8503, Japan
| | - Machiko Kawamura
- Department of Hematology, Saitama Cancer Center, Inamachi 362-0806, Japan
| | - Noboru Yokoyama
- Digestive Disease Center, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan
| | - Miki Kushima
- Department of Pathology, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan
| | - Haruhiro Inoue
- Digestive Disease Center, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan
| |
Collapse
|
5
|
Hara Y, Shiba N, Yoshida K, Yamato G, Kaburagi T, Shiraishi Y, Ohki K, Shiozawa Y, Kawamura M, Kawasaki H, Sotomatsu M, Takizawa T, Matsuo H, Shimada A, Kiyokawa N, Tomizawa D, Taga T, Ito E, Horibe K, Miyano S, Adachi S, Taki T, Ogawa S, Hayashi Y. TP53 and RB1 alterations characterize poor prognostic subgroups in pediatric acute myeloid leukemia. Genes Chromosomes Cancer 2023; 62:412-422. [PMID: 37102302 DOI: 10.1002/gcc.23147] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2023] [Revised: 04/10/2023] [Accepted: 04/11/2023] [Indexed: 04/28/2023] Open
Abstract
Pediatric acute myeloid leukemia (AML) is a poor prognostic subtype of pediatric leukemia. However, the detailed characteristics of many genetic abnormalities are yet to be established in this disease. Although TP53 and RB1 are established as representative tumor suppressor genes in various cancers, alterations of these two genes, especially RB1, have not been characterized in pediatric AML. We performed next-generation sequencing in 328 pediatric AML patients from the Japanese AML-05 trial to ascertain TP53 and RB1 alterations, and their prognostic implications. We identified seven patients with TP53 alterations (2.1%) and six patients with RB1 alterations (1.8%). These alterations were found in only patients without RUNX1::RUNX1T1, CBFB::MYH11, or KMT2A rearrangements. TP53 and RB1 were frequently co-deleted with their neighboring genes PRPF8 and ELF1, respectively. Patients with TP53 alterations had significantly lower 5-year overall survival (OS; 14.3% vs. 71.4%, p < 0.001) and lower 5-year event-free survival (EFS; 0% vs. 56.3%, p < 0.001); similarly, patients with RB1 had significantly lower 5-year OS (0% vs. 71.8%, p < 0.001) and lower 5-year EFS (0% vs. 56.0%, p < 0.001) when compared to patients without these alterations. In gene expression analyses, oxidative phosphorylation, glycolysis, and protein secretion were upregulated in patients with TP53 and/or RB1 alterations. Additionally, Kaplan-Meier analysis revealed that high expressions of SLC2A5, KCNAB2, and CD300LF were related to poor OS of non-core-binding factor AML patients (p < 0.001, p = 0.001, and p = 0.021, respectively). This study will contribute to the development of risk-stratified therapy and precision medicine in pediatric AML.
Collapse
Affiliation(s)
- Yusuke Hara
- Department of Pediatrics, Gunma University Graduate School of Medicine, Maebashi, Japan
| | - Norio Shiba
- Department of Pediatrics, Yokohama City University Hospital, Yokohama, Japan
| | - Kenichi Yoshida
- Division of Cancer Evolution, National Cancer Center Research Institute, Tokyo, Japan
- Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan
| | - Genki Yamato
- Department of Pediatrics, Gunma University Graduate School of Medicine, Maebashi, Japan
- Department of Hematology and Oncology, Gunma Children's Medical Center, Shibukawa, Japan
| | - Taeko Kaburagi
- Department of Pediatrics, Gunma University Graduate School of Medicine, Maebashi, Japan
- Department of Hematology and Oncology, Gunma Children's Medical Center, Shibukawa, Japan
| | - Yuichi Shiraishi
- Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan
| | - Kentaro Ohki
- Department of Hematology and Oncology, Gunma Children's Medical Center, Shibukawa, Japan
- Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Tokyo, Japan
| | - Yusuke Shiozawa
- Laboratory of Molecular Analysis, Nippon Medical School, Tokyo, Japan
| | - Machiko Kawamura
- Department of Clinical Laboratory Medicine, Saitama Cancer Center, Saitama, Japan
| | - Hirohide Kawasaki
- Department of Hematology and Oncology, Gunma Children's Medical Center, Shibukawa, Japan
| | - Manabu Sotomatsu
- Department of Hematology and Oncology, Gunma Children's Medical Center, Shibukawa, Japan
| | - Takumi Takizawa
- Department of Pediatrics, Gunma University Graduate School of Medicine, Maebashi, Japan
| | - Hidemasa Matsuo
- Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - Akira Shimada
- Department of Pediatrics, Jichi Medical University, Shimotsuke, Japan
| | - Nobutaka Kiyokawa
- Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Tokyo, Japan
| | - Daisuke Tomizawa
- Division of Leukemia and Lymphoma, Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan
| | - Takashi Taga
- Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan
| | - Etsuro Ito
- Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
| | - Keizo Horibe
- Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
| | - Satoru Miyano
- M&D Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan
| | - Souichi Adachi
- Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - Tomohiko Taki
- Department of Medical Technology, Kyorin University Faculty of Health Sciences, Mitaka, Japan
| | - Seishi Ogawa
- Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan
- Department of Pathology and Tumor Biology, Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan
- Department of Medicine, Centre for Hematology and Regenerative Medicine, Karolinska Institute, Stockholm, Sweden
| | - Yasuhide Hayashi
- Department of Hematology and Oncology, Gunma Children's Medical Center, Shibukawa, Japan
- Institute of Physiology and Medicine, Jobu University, Takasaki, Japan
| |
Collapse
|
6
|
Sekiguchi Y, Tsutsumi H, Gomyo A, Kudo M, Iizaki Y, Maseki N, Kawamura M, Kobayashi K, Nishimura Y, Kanda H, Nitta H, Noguchi M, Kobayashi H. Use of R-mini-CHP in combination with polatuzumab vedotin (pola-R-mini-CHP) as the primary treatment in ≥80-year-old cases with diffuse large B-cell lymphoma. J Clin Exp Hematop 2023; 63:262-265. [PMID: 38148017 PMCID: PMC10861370 DOI: 10.3960/jslrt.23043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2023] Open
Affiliation(s)
| | - Hiroki Tsutsumi
- Department of Hematology, Saitama Cancer Center, Saitama, Japan
| | - Ayumi Gomyo
- Department of Hematology, Saitama Cancer Center, Saitama, Japan
| | - Masahisa Kudo
- Department of Hematology, Saitama Cancer Center, Saitama, Japan
| | - Yoshie Iizaki
- Department of Hematology, Saitama Cancer Center, Saitama, Japan
| | - Nobuo Maseki
- Department of Hematology, Saitama Cancer Center, Saitama, Japan
| | - Machiko Kawamura
- Department of Hematology, Saitama Cancer Center, Saitama, Japan
- Department of Clinical Laboratory Medicine, Saitama Cancer Center, Saitama, Japan
| | - Kazuhiko Kobayashi
- Department of Inspection Engineering, Saitama Cancer Center, Saitama, Japan
| | - Yu Nishimura
- Department of Pathology, Saitama Cancer Center, Saitama, Japan
| | - Hiroaki Kanda
- Department of Pathology, Saitama Cancer Center, Saitama, Japan
| | - Hideaki Nitta
- Department of Hematology, Juntendo University Urayasu Hospital, Chiba, Japan
| | - Masaaki Noguchi
- Department of Hematology, Juntendo University Urayasu Hospital, Chiba, Japan
| | | |
Collapse
|
7
|
Sekiguchi Y, Nishimura Y, Kanda H, Kawamura M, Kobayashi K, Misaki Y, Takazawa Y, Kobayashi H. A Case of Diffuse Large B-Cell Lymphoma Complicated by Helicobacter Pylori-Negative Russell Body Gastritis. Gan To Kagaku Ryoho 2022; 49:1233-1239. [PMID: 36412027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Abstract
A 76-year-old woman with a past history of diabetes mellitus and Hashimoto's disease, in regard to her personal history, she did not smoke or drink alcohol. In March, year X-1, she became aware of cervical lymphadenopathy. Based on the findings of lymph node biopsy, she was diagnosed as having diffuse large B-cell lymphoma(DLBCL). An upper gastrointestinal endoscopy(U-GIE)revealed white granular prominences in the gastric fornix, and biopsy of these lesions revealed the diagnosis of Russell body gastritis(RBG). Neither lymphoma infiltration nor other malignant findings were found. Diagnostic tests for Helicobacter pylori were negative. The clinical stage of the DLBCL was determined as stage ⅢA, and the International Prognostic Index was"high intermediate". She received 6 cycles of R-CHOP therapy, with concomitant use of a proton pump inhibitor. Complete remission was confirmed in November, year X-1. An U-GIE performed again no longer showed the white granular prominences in the gastric fornix. The present report is the first of DLBCL complicated by RBG; our findings suggested that the two diseases were associated with each other.
Collapse
|
8
|
Yamauchi Y, Yamamoto Y, Yokote F, Dejima H, Saito Y, Sakao Y, Kawamura M. EP16.01-028 Immunomodulatory Effects of Cryoablation Combined With Immune Checkpoint Inhibitors in a Murine Lung Cancer Model. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.1027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
9
|
Yamauchi Y, Kawamura M, Okami J, Shintani Y, Ito H, Ohtsuka T, Toyooka S, Mori T, Watanabe SI, Asamura H, Chida M, Endo S, Kadokura M, Nakanishi R, Miyaoka E, Yoshino I, Date H. 944P Hazard function analysis of recurrence in patients with curatively resected lung cancer: Results from the Japanese Lung Cancer Registry in 2010. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.1069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
10
|
Sekiguchi Y, Nishimura Y, Kanda H, Kawamura M, Kobayashi K, Kobayashi H. Waldenstrom Macroglobulinemia/Lymphoplasmacytic Lymphoma Associated with Nephrotic Syndrome during Hemodialysis, Treated Successfully with Tirabrutinib. Intern Med 2022; 61:2503-2508. [PMID: 35110483 PMCID: PMC9449620 DOI: 10.2169/internalmedicine.8760-21] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
A 74-year-old woman was diagnosed with Waldenstrom macroglobulinemia/lymphoplasmacytic lymphoma (WM/LPL) in X-18. Fludarabine plus rituximab (FR) was started, and she showed remission. In July X-7, the serum creatinine (Cr) level increased to 1.67 mg/dL, and bendamustine plus rituximab (BR) was started. By November X-7, the Cr level had increased to 8.41 mg/dL, so she was started on hemodialysis (HD). In September X-1, she developed nephrotic syndrome. She was started on tirabrutinib at 480 mg. In July X, her nephrotic syndrome had improved, and a complete response (CR) was achieved. This is the first case of the administration of tirabrutinib in a patient undergoing HD.
Collapse
Affiliation(s)
| | - You Nishimura
- Department of Pathology, Saitama Cancer Center, Japan
| | - Hiroaki Kanda
- Department of Pathology, Saitama Cancer Center, Japan
| | - Machiko Kawamura
- Department of Clinical Laboratory Medicine, Saitama Cancer Center, Japan
| | - Kazuhiko Kobayashi
- Department of Clinical Laboratory Medicine, Saitama Cancer Center, Japan
| | | |
Collapse
|
11
|
Sekiguchi Y, Ishikawa A, Kanda H, Kawamura M, Tomita S, Noguchi M. A Case of EBER Positive Angioimmunoblastic T-cell Lymphoma Combined with Myxofibrosarcoma of the Pleura. Tokai J Exp Clin Med 2022; 47:1-8. [PMID: 35383862] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Received: 09/13/2021] [Accepted: 11/02/2021] [Indexed: 06/14/2023]
Abstract
A 76-year-man presented with generalized lymphadenopathy. Lymph node biopsy led to the diagnosis of Epstein-Barr virus-encoded small RNA in situ hybridization (EBER)-positive angioimmunoblastic T-cell lymphoma (AITL). He was initiated on treatment with oral prednisolone (PSL) at the dose of 50 mg/day; however, he was diagnosed as having right pleural effusion. He was started on treatment with cyclophosphamide, doxorubicin, vincristine and PSL (CHOP therapy). However, the right pleural effusion increased in size, and thoracentesis was performed. The aspirated pleural fluid was bloody, and since only a very small number of atypical cells were found, no definitive diagnosis could be made. CT revealed multiple nodular lesions in the pleura, and thoracoscopy was performed, which revealed jelly-like white lesions in the right parietal pleura. Biopsy raised the suspicion of undifferentiated pleomorphic sarcoma (UPS). Treatment with carboplatin and pemetrexed was started, but his respiratory symptoms worsened and he died. Autopsy revealed evidence of complete remission of AITL and myxofibrosarcoma (MFS) of the pleura. This is the first reported case of AITL combined with MFS.
Collapse
Affiliation(s)
- Yasunobu Sekiguchi
- Department of Hematology, Saitama Cancer Center, 780 Komuro, Ina, Kita-adachi-gun, Saitama 362-0806, Japan.
| | | | | | | | | | | |
Collapse
|
12
|
Yokota K, Hinoki A, Hiramatsu K, Amano H, Kawamura M, Kuwatsuka Y, Tainaka T, Shirota C, Sumida W, Makita S, Okamoto M, Takimoto A, Yasui A, Nakagawa Y, Uchida H, Kawakita M. Urinary N 1,N 12-diacetylspermine as a biomarker for pediatric cancer: a case-control study. Pediatr Surg Int 2021; 37:1659-1665. [PMID: 34453590 DOI: 10.1007/s00383-021-04987-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 08/01/2021] [Indexed: 10/20/2022]
Abstract
PURPOSE Minimally invasive examinations are particularly important in pediatric patients. Although the significance of urinary N1,N12-diacetylspermine (DiAcSpm) as a tumor marker (TM) has been reported in many types of adult cancers, its usefulness in pediatric cancers has not been reported. This may be due to urinary DiAcSpm level variations with age. This study aims to measure the normal levels of urinary DiAcSpm in healthy individuals and investigate its usefulness as a TM in childhood cancer. METHODS Urinary samples were collected from pediatric patients with and without cancer. The urinary DiAcSpm levels were measured, and the values were compared. RESULTS A total of 32 patients with cancer and 405 controls were enrolled in the study. Of the 32 patients, 13 had neuroblastoma, 9 had malignant lymphoma (ML), and 10 had leukemia. In the control group, the urinary DiAcSpm values markedly fluctuated among those with young age, especially infants; meanwhile, the values converged among those aged roughly 10 years and above. The sensitivity of DiAcSpm was significantly different among the three types of cancers: neuroblastoma (30.8%), ML (77.8%), and leukemia (40%). CONCLUSION The urinary DiAcSpm value is a useful TM for both screening and follow-up of ML.
Collapse
Affiliation(s)
- Kazuki Yokota
- Department of Pediatric Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumaicho, Showa, Nagoya, 466-8550, Japan
| | - Akinari Hinoki
- Department of Rare/Refractory Cancer Analysis Research, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Kyoko Hiramatsu
- Stem Cell Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
| | - Hizuru Amano
- Department of Pediatric Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumaicho, Showa, Nagoya, 466-8550, Japan
| | - Machiko Kawamura
- Department of Hematology, Saitama Cancer Center, Saitama, Japan.,Department of Pediatrics, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan
| | - Yachiyo Kuwatsuka
- Center for Advanced Medicine and Clinical Research, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Takahisa Tainaka
- Department of Pediatric Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumaicho, Showa, Nagoya, 466-8550, Japan
| | - Chiyoe Shirota
- Department of Pediatric Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumaicho, Showa, Nagoya, 466-8550, Japan
| | - Wataru Sumida
- Department of Pediatric Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumaicho, Showa, Nagoya, 466-8550, Japan
| | - Satoshi Makita
- Department of Pediatric Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumaicho, Showa, Nagoya, 466-8550, Japan
| | - Masamune Okamoto
- Department of Pediatric Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumaicho, Showa, Nagoya, 466-8550, Japan
| | - Aitaro Takimoto
- Department of Pediatric Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumaicho, Showa, Nagoya, 466-8550, Japan
| | - Akihiro Yasui
- Department of Pediatric Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumaicho, Showa, Nagoya, 466-8550, Japan
| | - Yoichi Nakagawa
- Department of Pediatric Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumaicho, Showa, Nagoya, 466-8550, Japan
| | - Hiroo Uchida
- Department of Pediatric Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumaicho, Showa, Nagoya, 466-8550, Japan.
| | - Masao Kawakita
- Stem Cell Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
| |
Collapse
|
13
|
Kawahara D, Nishibuchi I, Kawamura M, Yoshida T, Nagata Y. Radiomic Analysis for Pretreatment Prediction of Recurrence after Radiotherapy in Locally Advanced Cervical Cancer. Int J Radiat Oncol Biol Phys 2021. [DOI: 10.1016/j.ijrobp.2021.07.477] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
14
|
Saito Y, Yokote F, Takeuchi K, Honda T, Numakura S, Dejima H, Sakuramachi M, Yamauchi Y, Mori T, Motoi N, Shiraishi K, Saito K, Seki N, Sakao Y, Kawamura M. P41.02 Surgery for Small Pulmonary NUT Carcinoma: Case Report. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.08.459] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
15
|
Saito Y, Matsui A, Michiyuki S, Morooka H, Ibi T, Yamauchi Y, Takahashi N, Shimizu Y, Ikeya T, Hoshi E, Sakao Y, Kawamura M. 1794P Rapid diagnosis of liquid biopsy in non-small cell lung cancer by the EGFR-LAMP assay. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.1736] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
16
|
Takase Y, Kawamura M, Nakahara R, Itoh J, Oie Y, Okumura M, Kamomae T, Itoh Y, Ono T, Naganawa S. PO-1036 Malignant. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)07487-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
17
|
Kawamura M, Nakahara R, Ishihara S, Oie Y, Takase Y, Okumura M, Ito J, Ono T, Itoh Y, Naganawa S. PO-1291 Can we safely lower the RT dose with the use of high dose PF for advanced cervical cancer? Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)07742-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
18
|
Maryenko D, Kawamura M, Ernst A, Dugaev VK, Sherman EY, Kriener M, Bahramy MS, Kozuka Y, Kawasaki M. Interplay of spin-orbit coupling and Coulomb interaction in ZnO-based electron system. Nat Commun 2021; 12:3180. [PMID: 34039969 PMCID: PMC8155003 DOI: 10.1038/s41467-021-23483-4] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2020] [Accepted: 04/30/2021] [Indexed: 11/09/2022] Open
Abstract
Spin-orbit coupling (SOC) is pivotal for various fundamental spin-dependent phenomena in solids and their technological applications. In semiconductors, these phenomena have been so far studied in relatively weak electron-electron interaction regimes, where the single electron picture holds. However, SOC can profoundly compete against Coulomb interaction, which could lead to the emergence of unconventional electronic phases. Since SOC depends on the electric field in the crystal including contributions of itinerant electrons, electron-electron interactions can modify this coupling. Here we demonstrate the emergence of the SOC effect in a high-mobility two-dimensional electron system in a simple band structure MgZnO/ZnO semiconductor. This electron system also features strong electron-electron interaction effects. By changing the carrier density with Mg-content, we tune the SOC strength and achieve its interplay with electron-electron interaction. These systems pave a way to emergent spintronic phenomena in strong electron correlation regimes and to the formation of quasiparticles with the electron spin strongly coupled to the density.
Collapse
Affiliation(s)
- D Maryenko
- RIKEN Center for Emergent Matter Science(CEMS), Wako, Japan.
| | - M Kawamura
- RIKEN Center for Emergent Matter Science(CEMS), Wako, Japan
| | - A Ernst
- Institute for Theoretical Physics, Johannes Kepler University, Linz, Austria.,Max Planck Institute of Microstructure Physics, Halle, Germany
| | - V K Dugaev
- Department of Physics and Medical Engineering, Rzeszów University of Technology, Rzeszów, Poland
| | - E Ya Sherman
- Department of Physical Chemistry, University of the Basque Country UPV/EHU, Bilbao, Spain.,Ikerbasque, Basque Foundation for Science, Bilbao, Spain
| | - M Kriener
- RIKEN Center for Emergent Matter Science(CEMS), Wako, Japan
| | - M S Bahramy
- Department of Applied Physics and Quantum-Phase Electronics Center (QPEC), The University of Tokyo, Tokyo, Japan.,Department of Physics and Astronomy, The University of Manchester, Manchester, UK
| | - Y Kozuka
- Research Center for Magnetic and Spintronic Materials, National Institute for Materials Science (NIMS), Tsukuba, Japan.,JST, PRESTO, Kawaguchi, Saitama, Japan
| | - M Kawasaki
- RIKEN Center for Emergent Matter Science(CEMS), Wako, Japan.,Department of Applied Physics and Quantum-Phase Electronics Center (QPEC), The University of Tokyo, Tokyo, Japan
| |
Collapse
|
19
|
Yamauchi Y, Saito Y, Shirai S, Yokote F, Sakai T, Dejima H, Sakao Y, Kawamura M. P04.08 Dynamics of Coagulation Factor XIII Activity After Thoracoscopic Lobectomy for Early-Stage Lung Cancer Patients. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.01.387] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
20
|
Ito H, Uragami N, Miyazaki T, Yang W, Issha K, Matsuo K, Kimura S, Arai Y, Tokunaga H, Okada S, Kawamura M, Yokoyama N, Kushima M, Inoue H, Fukagai T, Kamijo Y. Highly accurate colorectal cancer prediction model based on Raman spectroscopy using patient serum. World J Gastrointest Oncol 2020; 12:1311-1324. [PMID: 33250963 PMCID: PMC7667458 DOI: 10.4251/wjgo.v12.i11.1311] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/31/2020] [Revised: 09/28/2020] [Accepted: 10/19/2020] [Indexed: 02/05/2023] Open
Abstract
BACKGROUND Colorectal cancer (CRC) is an important disease worldwide, accounting for the second highest number of cancer-related deaths and the third highest number of new cancer cases. The blood test is a simple and minimally invasive diagnostic test. However, there is currently no blood test that can accurately diagnose CRC.
AIM To develop a comprehensive, spontaneous, minimally invasive, label-free, blood-based CRC screening technique based on Raman spectroscopy.
METHODS We used Raman spectra recorded using 184 serum samples obtained from patients undergoing colonoscopies. Patients with malignant tumor histories as well as those with cancers in organs other than the large intestine were excluded. Consequently, the specific diseases of 184 patients were CRC (12), rectal neuroendocrine tumor (2), colorectal adenoma (68), colorectal hyperplastic polyp (18), and others (84). We used the 1064-nm wavelength laser for excitation. The power of the laser was set to 200 mW.
RESULTS Use of the recorded Raman spectra as training data allowed the construction of a boosted tree CRC prediction model based on machine learning. Therefore, the generalized R2 values for CRC, adenomas, hyperplastic polyps, and neuroendocrine tumors were 0.9982, 0.9630, 0.9962, and 0.9986, respectively.
CONCLUSION For machine learning using Raman spectral data, a highly accurate CRC prediction model with a high R2 value was constructed. We are currently planning studies to demonstrate the accuracy of this model with a large amount of additional data.
Collapse
Affiliation(s)
- Hiroaki Ito
- Digestive Disease Center, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan
| | - Naoyuki Uragami
- Digestive Disease Center, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan
| | | | | | - Kenji Issha
- Fuji Technical Research Inc., Yokohama 220-6215, Japan
| | - Kai Matsuo
- Digestive Disease Center, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan
| | - Satoshi Kimura
- Department of Laboratory Medicine and Central Clinical Laboratory, Showa University Northern Yokohama Hospital, Yokohama 224-8503, Japan
| | - Yuji Arai
- Department of Clinical Laboratory, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan
| | - Hiromasa Tokunaga
- Department of Clinical Laboratory, Showa University Hospital, Tokyo 142-8555, Japan, BML Inc., Tokyo 151-0051, Japan
| | - Saiko Okada
- Department of Clinical Laboratory, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan
| | - Machiko Kawamura
- Department of Hematology, Saitama Cancer Center, Inamachi, Saitama 362-0806, Japan
| | - Noboru Yokoyama
- Digestive Disease Center, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan
| | - Miki Kushima
- Department of Pathology, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan
| | - Haruhiro Inoue
- Digestive Disease Center, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan
| | - Takashi Fukagai
- Department of Urology, Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan
| | - Yumi Kamijo
- Showa University Koto Toyosu Hospital, Tokyo 135-8577, Japan
| |
Collapse
|
21
|
Kasai F, Asou H, Ozawa M, Kobayashi K, Kuramitsu H, Satoh M, Kohara A, Kaneko Y, Kawamura M. Kasumi leukemia cell lines: characterization of tumor genomes with ethnic origin and scales of genomic alterations. Hum Cell 2020; 33:868-876. [PMID: 32180206 PMCID: PMC7324421 DOI: 10.1007/s13577-020-00347-5] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2020] [Accepted: 03/05/2020] [Indexed: 01/08/2023]
Abstract
Kasumi-1 has played an important role in an experimental model with t(8;21) translocation, which is a representative example of leukemia cell lines. However, previous studies using Kasumi-1 show discrepancies in the genome profile. The wide use of leukemia cell lines is limited to lines that are well-characterized. The use of additional cell lines extends research to various types of leukemia, and to further explore leukemia pathogenesis, which can be achieved by uncovering the fundamental features of each cell line with accurate data. In this study, ten Kasumi cell lines established in Japan, including five that were previously unknown, have been characterized by SNP microarray and targeted sequencing. SNP genotyping suggested that the genetic ancestry in four of the ten Kasumi cell lines was not classified as Japanese but covered several different east-Asian ethnicities, suggesting that patients in Japan are genetically diverse. TP53 mutations were detected in two cell lines with complex array profiles, indicating chromosomal instability (CIN). A quantitative assessment of tumor genomes at the chromosomal level was newly introduced to reveal total DNA sizes and Scales of Genomic Alterations (SGA) for each cell line. Kasumi-1 and 6 derived from relapsed phases demonstrated high levels of SGA, implying that the level of SGA would reflect on the tumor progression and could serve as an index of CIN. Our results extend the leukemia cellular resources with an additional five cell lines and provide reference genome data with ethnic identities for the ten Kasumi cell lines.
Collapse
Affiliation(s)
- Fumio Kasai
- Japanese Collection of Research Bioresources (JCRB) Cell Bank, National Institutes of Biomedical Innovation, Health and Nutrition, Saito-Asagi 7-6-8, Ibaraki, Osaka, 567-0085, Japan.
| | - Hiroya Asou
- Medicine Development Unit, Eli Lilly, Kobe, 651-0086, Japan
| | - Midori Ozawa
- Japanese Collection of Research Bioresources (JCRB) Cell Bank, National Institutes of Biomedical Innovation, Health and Nutrition, Saito-Asagi 7-6-8, Ibaraki, Osaka, 567-0085, Japan
| | - Kazuhiko Kobayashi
- Department of Clinical Laboratory, Saitama Cancer Center, Saitama, 362-0806, Japan
| | - Hiroyuki Kuramitsu
- Department of Clinical Laboratory, Saitama Cancer Center, Saitama, 362-0806, Japan
| | - Motonobu Satoh
- Japanese Collection of Research Bioresources (JCRB) Cell Bank, National Institutes of Biomedical Innovation, Health and Nutrition, Saito-Asagi 7-6-8, Ibaraki, Osaka, 567-0085, Japan
| | - Arihiro Kohara
- Japanese Collection of Research Bioresources (JCRB) Cell Bank, National Institutes of Biomedical Innovation, Health and Nutrition, Saito-Asagi 7-6-8, Ibaraki, Osaka, 567-0085, Japan
| | - Yasuhiko Kaneko
- Research Institute for Clinical Oncology, Saitama Cancer Center, Saitama, 362-0806, Japan.,Department of Hematology, Saitama Cancer Center, Saitama, 362-0806, Japan
| | - Machiko Kawamura
- Department of Clinical Laboratory, Saitama Cancer Center, Saitama, 362-0806, Japan.,Department of Hematology, Saitama Cancer Center, Saitama, 362-0806, Japan
| |
Collapse
|
22
|
Kawamura M, Sato T, Fujimura S. In vitro exposure of chlorhexidine induce quinolone resistance in Pseudomonas aeruginosa. J Infect Public Health 2020. [DOI: 10.1016/j.jiph.2020.01.034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
23
|
Fujimura S, Nagasawa T, Kawamura M, Sato T, Sato T. The sterilization effect against Staphylococcus aureus and Pseudomonas aeruginosa on the contact lens using the Ultraviolet C irradiation. J Infect Public Health 2020. [DOI: 10.1016/j.jiph.2020.01.119] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
24
|
Kawamura M, Yoshiyuki I, Kamomae T, Ito J, Oie Y, Ohtakara K, Naganawa S. PO-143: A phase I/II trial of intraoperative breast radiotherapy in an Asian population: 10-year results. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(20)30485-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
25
|
Yamada R, Fujioka J, Kawamura M, Sakai S, Hirayama M, Arita R, Okawa T, Hashizume D, Hoshino M, Tokura Y. Large Variation of Dirac Semimetal State in Perovskite CaIrO_{3} with Pressure-Tuning of Electron Correlation. Phys Rev Lett 2019; 123:216601. [PMID: 31809165 DOI: 10.1103/physrevlett.123.216601] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/24/2019] [Revised: 09/16/2019] [Indexed: 06/10/2023]
Abstract
The impact of electron correlation on the Dirac semimetal state is investigated for perovskite CaIrO_{3} in terms of the magnetotransport properties under varying pressures. The reduction of electron correlation with a pressure of 1 GPa enhances the Fermi velocity as much as 40%, but it reduces the mobility by an order of magnitude by detuning the Dirac node from the Fermi energy. Moreover, the giant magnetoresistance at the quantum limit due to the one-dimensional confinement of Dirac electrons is critically suppressed under pressure. These results indicate that the electron correlation is a crucial knob for controlling the transport of a correlated Dirac semimetal.
Collapse
Affiliation(s)
- R Yamada
- Department of Applied Physics, University of Tokyo, Tokyo 113-8656, Japan
| | - J Fujioka
- Faculty of Pure and Applied Sciences, University of Tsukuba, Tsukuba 305-8577, Japan
| | - M Kawamura
- RIKEN Center for Emergent Matter Science (CEMS), Wako 351-0198, Japan
| | - S Sakai
- RIKEN Center for Emergent Matter Science (CEMS), Wako 351-0198, Japan
| | - M Hirayama
- RIKEN Center for Emergent Matter Science (CEMS), Wako 351-0198, Japan
| | - R Arita
- Department of Applied Physics, University of Tokyo, Tokyo 113-8656, Japan
- RIKEN Center for Emergent Matter Science (CEMS), Wako 351-0198, Japan
| | - T Okawa
- Department of Applied Physics, University of Tokyo, Tokyo 113-8656, Japan
| | - D Hashizume
- RIKEN Center for Emergent Matter Science (CEMS), Wako 351-0198, Japan
| | - M Hoshino
- RIKEN Center for Emergent Matter Science (CEMS), Wako 351-0198, Japan
| | - Y Tokura
- Department of Applied Physics, University of Tokyo, Tokyo 113-8656, Japan
- RIKEN Center for Emergent Matter Science (CEMS), Wako 351-0198, Japan
- Tokyo College, University of Tokyo, Tokyo 113-8656, Japan
| |
Collapse
|
26
|
Onishi Y, Yoshikawa K, Tanisawa H, Ochi A, Ito H, Kawamura M, Kobayashi Y, Shinke T. P977Selective liner ablation according to the type of tachycardia induced after pulmonary vein isolation in single-procedure for long-standing persistent atrial fibrillation. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz747.0570] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
The most effective approach for long-standing persistent atrial fibrillation (LSPAF) ablation remained undetermined. Here, we hypothesized that selective linear ablation (SLA) according to the type of tachycardia induced by burst atrial pacing (BAP) after pulmonary venous isolation (PVI) in single-procedure reduces the recurrence.
Methods
A cohort of 66 LSPAF patients (Mean age 71.0±8.2 years, AF duration 40.5±58.8 months) who underwent PVI in single-procedure between April 2016 and November 2018 was evaluated.
Results
Any sustained atrial tachycardia (AT) or AF were not inducible by BAP after PVI in 21 patients (Non-inducible group, 31.8%, 71.3±7.9 years, 34.4±54.2 months). These patients underwent cavo-tricuspid isthmus (CTI) ablation after PVI. Forty-one patients underwent selective liner ablation according to the type of tachycardia induced by BAP after PVI (SLA group, 62.1%, 71.2±8.3 years, 39.3±55.6 months). Maccroreentry ATs (6 common atrial flutter, 5 AT originating from left atrial anterior wall, 2 peri-mitral atrial flutter, 1 roof-dependent atrial flutter) were induced by BAP in 14 patients of SLA group (73.2±19.7 years, 51.7±83.5 months). RF applications created the complete linear lesions to terminate maccroreentry ATs. Sustained AF was induced by BAP after PVI in 27 patients of SLA group (70.2±9.2 years, 32.9±31.2 months). These patients underwent posterior wall isolation (PWI) and CTI ablation. Unmappable AT was induced by BAP after PVI in 4 patients (Non-SLA group, 6.1%, 67.0±9.7 years, 84.5±105.6 months). These patients underwent PWI, CTI and mitral isthmus ablation on an empirical basis instead of SLA. Using a 90-day blanking period, the single-procedure Kaplan-Meier estimates of AT or AF event-free survival were 79% at 12 months. During follow-up (14.5±8.0 months), although 19 /21 (90.5%) of Non-inducible group patients and 33/41 (80.5%) of SLA group patients did not experience AT or AF recurrence, all of Non-SLA group patients experienced AF recurrence. There was no difference between Non-inducible group and SLA group in predicting recurrence of AT or AF (p=0.3). However, there was a difference when compared with Non-SLA group (each p<0.001). Non-SLA group was an independent powerful predictor resulting in recurrence of AF after adjusting for potential confounding factors (adjusted hazard ratio = 7.17; 95% confidence interval; 2.2–23.1, p=0.001, Wald χ2=10.9). Furthermore, in Kaplan-Meier survival curves for predicting AT or AF recurrence, Non-SLA group was the significant predictive marker of AT or AF recurrence (Log-Lank χ2=18.0, p<0.001).
Kaplan-Meier survival curves
Conclusions
In LSPAF patients without inducibility of any tachycardia after PVI, sinus rhythm was highly maintained without stepwise ablation other than CTI ablation. SLA reduced recurrence of AF in LSPAF patients with AT and AF induced after PVI. In addition, nonselective liner ablations for unmappable AT after PVI were less effective in LSPAF patients.
Collapse
Affiliation(s)
- Y Onishi
- Showa University, Division of Cardiology, Department of Medicine, Tokyo, Japan
| | - K Yoshikawa
- Showa University, Division of Cardiology, Department of Medicine, Tokyo, Japan
| | - H Tanisawa
- Showa University, Division of Cardiology, Department of Medicine, Tokyo, Japan
| | - A Ochi
- Showa University, Division of Cardiology, Department of Medicine, Tokyo, Japan
| | - H Ito
- Showa University, Division of Cardiology, Department of Medicine, Tokyo, Japan
| | - M Kawamura
- Showa University, Division of Cardiology, Department of Medicine, Tokyo, Japan
| | - Y Kobayashi
- Showa University, Division of Cardiology, Department of Medicine, Tokyo, Japan
| | - T Shinke
- Showa University, Division of Cardiology, Department of Medicine, Tokyo, Japan
| |
Collapse
|
27
|
Sakai T, Yamauchi Y, Yokote F, Saito Y, Uehara H, Saito K, Sakao Y, Kawamura M. EP1.15-23 Cardiac Tamponade Caused by a Type A Thymoma: A Case Report. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.2358] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
28
|
Yokote F, Yamauchi Y, Sakai T, Saito Y, Uehara H, Sakao Y, Kawamura M. EP1.17-07 Partial Anomalous Pulmonary Venous Connection Found During a Lobectomy for Lung Cancer. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.2417] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
29
|
Munetsugu Y, Kawamura M, Ogawa K, Ochi A, Onishi Y, Ito H, Onuki T, Kobayashi Y, Shinke T. P5697J-wave elevation in the inferior leads is a predictor of lethal ventricular arrhythmia initiated by premature ventricular contractions with right bundle branch block and superior axis. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.0639] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Lethal-ventricular-arrhythmia (VA) could be sometimes initiated by idiopathic Premature Ventricular Contractions (PVCs) originated form inferior wall. Furthermore, J-wave elevation in inferior leads was sometimes associated with lethal-VA. However, it was unclear the relationship between these PVCs and J-wave elevation in patients with lethal-VA.
Purpose
The aim of this study was to investigate the relationship between PVCs and J-wave elevation.
Methods and results
We studied 32 patients who underwent radiofrequency (RF) ablation of idiopathic PVCs with RBBB and superior axis. These PVCs were originating from inferior wall of left ventricular. Lethal-VA was defined as ventricular fibrillation (VF) or ventricular tachycardia (VT) with loss of consciousness (LOC). Among 32 patients, 3 had VF and 2 had VT with LOC. Other 27 had non-lethal-VA. Baseline clinical characteristics were not significantly difference between lethal and non-lethal-VA. The ratio of J-wave elevation in lethal-VA was significant higher as compared to those with non-lethal-VA (5/5 (100%) vs. 3/27 (11.1%), p<0.0001). Furthermore, no patients had recurrence of lethal-VA with J wave elevation in inferior leads after RF ablation of these PVCs with RBBB and superior axis,
Conclusions
We speculated that J-wave elevation in inferior leads might be a predictor of lethal-VA initiated by PVCs with RBBB and superior axis. RF ablation of these PVCs were useful method of treating lethal-VA.
Acknowledgement/Funding
None
Collapse
Affiliation(s)
- Y Munetsugu
- Showa University School of Medicine, Department of Medicine, Division of Cardiology, Tokyo, Japan
| | - M Kawamura
- Showa University School of Medicine, Department of Medicine, Division of Cardiology, Tokyo, Japan
| | - K Ogawa
- Showa University School of Medicine, Department of Medicine, Division of Cardiology, Tokyo, Japan
| | - A Ochi
- Showa University School of Medicine, Department of Medicine, Division of Cardiology, Tokyo, Japan
| | - Y Onishi
- Showa University School of Medicine, Department of Medicine, Division of Cardiology, Tokyo, Japan
| | - H Ito
- Showa University School of Medicine, Department of Medicine, Division of Cardiology, Tokyo, Japan
| | - T Onuki
- Showa University School of Medicine, Department of Medicine, Division of Cardiology, Tokyo, Japan
| | - Y Kobayashi
- Showa University School of Medicine, Department of Medicine, Division of Cardiology, Tokyo, Japan
| | - T Shinke
- Showa University School of Medicine, Department of Medicine, Division of Cardiology, Tokyo, Japan
| |
Collapse
|
30
|
Oie Y, Itoh Y, Kawamura M, Takase Y, Murao T, Ishihara S, Nomoto Y, Hirasawa N, Asano A, Yamakawa K, Ito J, Naganawa S. Clinical Results of T1 Glottic Cancer Treated with Radiotherapy Using 2.25 Gy per Fractions: A Multicenter Survey in Clinical Practice. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.1708] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
31
|
Kawamura M, Koide Y, Murai T, Ishihara S, Takase Y, Murao T, Okazaki D, Yamaguchi T, Uchiyama K, Itoh Y, Kodaira T, Shibamoto Y, Mizuno M, Kikkawa F, Naganawa S. Should Small Cell Carcinoma of the Cervix be Treated As Localized Small Cell Cancer or Advanced Cervical Cancer: A Retrospective Multi-Institutional Cohort Study. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.1809] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
32
|
Fujioka J, Yamada R, Kawamura M, Sakai S, Hirayama M, Arita R, Okawa T, Hashizume D, Hoshino M, Tokura Y. Strong-correlation induced high-mobility electrons in Dirac semimetal of perovskite oxide. Nat Commun 2019; 10:362. [PMID: 30664632 PMCID: PMC6341165 DOI: 10.1038/s41467-018-08149-y] [Citation(s) in RCA: 43] [Impact Index Per Article: 8.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2018] [Accepted: 12/20/2018] [Indexed: 11/21/2022] Open
Abstract
Electrons in conventional metals become less mobile under the influence of electron correlation. Contrary to this empirical knowledge, we report here that electrons with the highest mobility ever found in known bulk oxide semiconductors emerge in the strong-correlation regime of the Dirac semimetal of perovskite CaIrO3. The transport measurements reveal that the high mobility exceeding 60,000 cm2V−1s−1 originates from the proximity of the Fermi energy to the Dirac node (ΔE < 10 meV). The calculation based on the density functional theory and the dynamical mean field theory reveals that the energy difference becomes smaller as the system approaches the Mott transition, highlighting a crucial role of correlation effects cooperating with the spin-orbit coupling. The correlation-induced self-tuning of Dirac node enables the quantum limit at a modest magnetic field with a giant magnetoresistance, thus providing an ideal platform to study the novel phenomena of correlated Dirac electron. Electron correlation normally makes electrons less mobile, but it is still not clear when correlation becomes very strong in Dirac semimetals. Here, Fujioka et al. report a very high electron mobility exceeding 60,000 cm2V−1s−1 in correlated Dirac semimetal of perovskite CaIrO3, due to the enhanced electron correlation nearby the Mott transition.
Collapse
Affiliation(s)
- J Fujioka
- Department of Applied Physics, University of Tokyo, Tokyo, 113-8656, Japan. .,PRESTO, Japan Science and Technology Agency, Kawaguchi, 332-0012, Japan. .,Graduate School of Pure and Applied Science, University of Tsukuba, Tsukuba, Ibaraki, Japan.
| | - R Yamada
- Department of Applied Physics, University of Tokyo, Tokyo, 113-8656, Japan
| | - M Kawamura
- RIKEN Center for Emergent Matter Science (CEMS), Wako, 351-0198, Japan
| | - S Sakai
- RIKEN Center for Emergent Matter Science (CEMS), Wako, 351-0198, Japan
| | - M Hirayama
- RIKEN Center for Emergent Matter Science (CEMS), Wako, 351-0198, Japan
| | - R Arita
- Department of Applied Physics, University of Tokyo, Tokyo, 113-8656, Japan.,RIKEN Center for Emergent Matter Science (CEMS), Wako, 351-0198, Japan
| | - T Okawa
- Department of Applied Physics, University of Tokyo, Tokyo, 113-8656, Japan
| | - D Hashizume
- RIKEN Center for Emergent Matter Science (CEMS), Wako, 351-0198, Japan
| | - M Hoshino
- PRESTO, Japan Science and Technology Agency, Kawaguchi, 332-0012, Japan.,RIKEN Center for Emergent Matter Science (CEMS), Wako, 351-0198, Japan
| | - Y Tokura
- Department of Applied Physics, University of Tokyo, Tokyo, 113-8656, Japan. .,RIKEN Center for Emergent Matter Science (CEMS), Wako, 351-0198, Japan.
| |
Collapse
|
33
|
Endoh M, Shiono S, Matsutani N, Okumura S, Ikeda N, Yoshino I, Nakajima J, Kawamura M. P3.08-08 Outcomes of Pulmonary Metastasectomy in Breast Cancer: Prognosis Based on the Metastatic Lung Tumor Study Group of Japan. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.1758] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
34
|
Iida Y, Yamauchi T, Yamazaki T, Ito T, Kawamura M, Okawa M, Imoto S. Effects of neuromuscular electrical stimulation and branched chain amino acid intake on recovery of muscle strength in sarcopenia patients undergoing cardiac surgery. Clin Nutr 2018. [DOI: 10.1016/j.clnu.2018.06.1148] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
35
|
Hashimoto H, Kawamura M, Yukami T, Ishihara M, Bamba Y, Kaneshiro S, Tsuboi H, Yamamoto K. Etiology of acute ischaemic cerebrovascular disease associated with rheumatoid arthritis: changes with progression of anti-inflammatory therapy. Eur J Neurol 2018; 25:1462-1469. [DOI: 10.1111/ene.13751] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2017] [Accepted: 07/10/2018] [Indexed: 11/30/2022]
Affiliation(s)
- H. Hashimoto
- Division of Hypertension and Stroke; Department of Internal Medicine; Osaka Rosai Hospital; Sakai-shi Japan
| | - M. Kawamura
- Division of Hypertension and Stroke; Department of Internal Medicine; Osaka Rosai Hospital; Sakai-shi Japan
| | - T. Yukami
- Division of Hypertension and Stroke; Department of Internal Medicine; Osaka Rosai Hospital; Sakai-shi Japan
| | - M. Ishihara
- Department of Neurosurgery; Osaka Rosai Hospital; Sakai-shi Japan
| | - Y. Bamba
- Department of Neurosurgery; Osaka Rosai Hospital; Sakai-shi Japan
| | - S. Kaneshiro
- Division of Rheumatology; Department of Orthopaedic Surgery; Osaka Rosai Hospital; Sakai-shi Japan
| | - H. Tsuboi
- Division of Rheumatology; Department of Orthopaedic Surgery; Osaka Rosai Hospital; Sakai-shi Japan
| | - K. Yamamoto
- Department of Neurosurgery; Osaka Rosai Hospital; Sakai-shi Japan
| |
Collapse
|
36
|
Onuki T, Gokan T, Nakamura Y, Okada N, Chiba Y, Kawasaki S, Onishi Y, Munetsugu Y, Ito H, Shoji M, Watanabe N, Minoura Y, Adachi T, Kawamura M, Kobayashi Y. P4833Risk predictors of supraventricular tachycardia and bradycardia necessitating therapy in patients with unexplained syncope receiving implantable loop recorder. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p4833] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- T Onuki
- Showa University Hospital, Division of Cardiology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan
| | - T Gokan
- Showa University Hospital, Division of Cardiology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan
| | - Y Nakamura
- Showa University Hospital, Division of Cardiology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan
| | - N Okada
- Showa University Hospital, Department of hospital pharmaceutics, Tokyo, Japan
| | - Y Chiba
- Showa University Hospital, Division of Cardiology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan
| | - S Kawasaki
- Showa University Hospital, Division of Cardiology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan
| | - Y Onishi
- Showa University Hospital, Division of Cardiology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan
| | - Y Munetsugu
- Showa University Hospital, Division of Cardiology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan
| | - H Ito
- Showa University Hospital, Division of Cardiology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan
| | - M Shoji
- Showa University Hospital, Division of Cardiology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan
| | - N Watanabe
- Showa University Hospital, Division of Cardiology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan
| | - Y Minoura
- Showa University Hospital, Division of Cardiology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan
| | - T Adachi
- Showa University Hospital, Division of Cardiology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan
| | - M Kawamura
- Showa University Hospital, Division of Cardiology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan
| | - Y Kobayashi
- Showa University Hospital, Division of Cardiology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan
| |
Collapse
|
37
|
Kawamura M, Mikami Y, Kajioka S, Kawamura R, Kimura H, Amano J. Characteristics of motor development of autism spectrum disorder children until unassisted walking stage. Ann Phys Rehabil Med 2018. [DOI: 10.1016/j.rehab.2018.05.696] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
38
|
Ichimaru N, Takayama T, Hirase H, Hisayama Y, Kawamura M, Nakazawa S, Kato T, Abe T, Kaimori JY, Imamura R, Nonomura N, Takahara S. Comparison of Sensitivity of Immunocomplex Capture Fluorescence Analysis for Detecting Donor-specific Anti-HLA Class II Antibodies in Kidney Transplant Patients. Transplant Proc 2018; 50:1074-1076. [PMID: 29731068 DOI: 10.1016/j.transproceed.2018.02.051] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2018] [Revised: 02/20/2018] [Accepted: 02/22/2018] [Indexed: 11/19/2022]
Abstract
BACKGROUND Immunocomplex capture fluorescence analysis (ICFA) detects donor-specific antihuman leukocyte antigen (HLA) antibodies (DSA), but the detection sensitivity of HLA class II antibodies using conventional ICFA is as low as 57%. The aim of the study was to improve the detection sensitivity of HLA class II antibodies by ICFA, and compare the ICFA results with the Luminex single-antigen bead test. METHODS Six DSA-negative kidney transplant donors and recipient pairs and 10 HLA class II DSA-positive pairs were included in the study. The detection sensitivity of modified ICFA was compared with conventional ICFA, and the ICFA results were compared with the Luminex single-antigen bead test. RESULTS The index value of modified ICFA was higher than that of conventional ICFA. The cutoff value of conventional ICFA was 30,686 (MFI), which was improved to 19,405 using modified ICFA. Regarding the HLA-DQ antibody, 5 samples found to be positive by Luminex single-antigen bead testing were all negative using modified ICFA. The reason for this discrepancy could be related to: (1) the difference in detection sensitivity; (2) the difference in HLA antigen surface expression between naive lymphocytes and synthetic beads; or (3) the structure of synthetic HLA DQ antigen on the Luminex single-antigen beads. CONCLUSION The index value of the modified ICFA was higher than that of conventional ICFA, and the detection sensitivity of HLA class II antibodies was improved by modified ICFA. Further assessment is necessary to clarify the reasons for divergence between ICFA and Luminex single-antigen bead test results.
Collapse
Affiliation(s)
- N Ichimaru
- Department of Advanced Technology for Transplantation, Osaka University, Suita, Japan.
| | - T Takayama
- Department of Laboratory for HLA, Osaka General Medical Center, Osaka, Japan
| | - H Hirase
- Department of Laboratory for HLA, Osaka General Medical Center, Osaka, Japan
| | - Y Hisayama
- Department of Laboratory for HLA, Osaka General Medical Center, Osaka, Japan
| | - M Kawamura
- Department of Urology, Osaka University, Suita, Japan
| | - S Nakazawa
- Department of Urology, Osaka University, Suita, Japan
| | - T Kato
- Department of Urology, Osaka University, Suita, Japan
| | - T Abe
- Department of Urology, Osaka University, Suita, Japan
| | - J-Y Kaimori
- Department of Advanced Technology for Transplantation, Osaka University, Suita, Japan
| | - R Imamura
- Department of Urology, Osaka University, Suita, Japan
| | - N Nonomura
- Department of Urology, Osaka University, Suita, Japan
| | - S Takahara
- Department of Advanced Technology for Transplantation, Osaka University, Suita, Japan
| |
Collapse
|
39
|
Kawamura M, Satoi E, Kiyoku R, Nozaka N, Matsuda M, Kanda R, Kiseki H. Delayed administration method of clomiphene citrate during the ovulatory phase in patients with a prolonged menstrual cycle. CLIN EXP OBSTET GYN 2018. [DOI: 10.12891/ceog3853.2018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]
|
40
|
Fujiwara T, Uotani K, Yoshida A, Morita T, Nezu Y, Kobayashi E, Yoshida A, Uehara T, Omori T, Sugiu K, Komatsubara T, Takeda K, Kunisada T, Kawamura M, Kawai A, Ochiya T, Ozaki T. Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma. Oncotarget 2018; 8:33375-33392. [PMID: 28380419 PMCID: PMC5464875 DOI: 10.18632/oncotarget.16498] [Citation(s) in RCA: 81] [Impact Index Per Article: 13.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2016] [Accepted: 02/27/2017] [Indexed: 02/06/2023] Open
Abstract
Background Emerging evidence has suggested that circulating microRNAs (miRNAs) in body fluids have novel diagnostic and prognostic significance for patients with malignant diseases. The lack of useful biomarkers is a crucial problem of bone and soft tissue sarcomas; therefore, we investigated the circulating miRNA signature and its clinical relevance in osteosarcoma. Methods Global miRNA profiling was performed using patient serum collected from a discovery cohort of osteosarcoma patients and controls and cell culture media. The secretion of the detected miRNAs from osteosarcoma cells and clinical relevance of serum miRNA levels were evaluated using in vitro and in vivo models and a validation patient cohort. Results Discovery screening identified 236 serum miRNAs that were highly expressed in osteosarcoma patients compared with controls, and eight among these were also identified in the cell culture media. Upregulated expression levels of miR-17-5p and miR-25-3p were identified in osteosarcoma cells, and these were abundantly secreted into the culture media in tumor-derived exosomes. Serum miR-25-3p levels were significantly higher in osteosarcoma patients than in control individuals in the validation cohort, with favorable sensitivity and specificity compared with serum alkaline phosphatase. Furthermore, serum miR-25-3p levels at diagnosis were correlated with patient prognosis and reflected tumor burden in both in vivo models and patients; these associations were more sensitive than those of serum alkaline phosphatase. Conclusions Serum-based circulating miR-25-3p may serve as a non-invasive blood-based biomarker for tumor monitoring and prognostic prediction in osteosarcoma patients.
Collapse
Affiliation(s)
- Tomohiro Fujiwara
- Department of Orthopedic Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.,Center of Innovative Medicine, Okayama University Hospital, Okayama, Japan.,Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo, Japan
| | - Koji Uotani
- Department of Orthopedic Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
| | - Aki Yoshida
- Department of Orthopedic Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
| | - Takuya Morita
- Department of Orthopedic Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
| | - Yutaka Nezu
- Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo, Japan
| | - Eisuke Kobayashi
- Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan
| | - Akihiko Yoshida
- Division of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan
| | - Takenori Uehara
- Department of Orthopedic Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
| | - Toshinori Omori
- Department of Orthopedic Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
| | - Kazuhisa Sugiu
- Department of Orthopedic Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
| | - Tadashi Komatsubara
- Department of Orthopedic Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
| | - Ken Takeda
- Department of Intelligent Orthopaedic System, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
| | - Toshiyuki Kunisada
- Department of Medical Materials for Musculoskeletal Reconstruction, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
| | | | - Akira Kawai
- Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan
| | - Takahiro Ochiya
- Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo, Japan
| | - Toshifumi Ozaki
- Department of Orthopedic Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
| |
Collapse
|
41
|
Giannozzi P, Andreussi O, Brumme T, Bunau O, Buongiorno Nardelli M, Calandra M, Car R, Cavazzoni C, Ceresoli D, Cococcioni M, Colonna N, Carnimeo I, Dal Corso A, de Gironcoli S, Delugas P, DiStasio RA, Ferretti A, Floris A, Fratesi G, Fugallo G, Gebauer R, Gerstmann U, Giustino F, Gorni T, Jia J, Kawamura M, Ko HY, Kokalj A, Küçükbenli E, Lazzeri M, Marsili M, Marzari N, Mauri F, Nguyen NL, Nguyen HV, Otero-de-la-Roza A, Paulatto L, Poncé S, Rocca D, Sabatini R, Santra B, Schlipf M, Seitsonen AP, Smogunov A, Timrov I, Thonhauser T, Umari P, Vast N, Wu X, Baroni S. Advanced capabilities for materials modelling with Quantum ESPRESSO. J Phys Condens Matter 2017; 29:465901. [PMID: 29064822 DOI: 10.1088/1361-648x/aa8f79] [Citation(s) in RCA: 1377] [Impact Index Per Article: 196.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/02/2023]
Abstract
Quantum EXPRESSO is an integrated suite of open-source computer codes for quantum simulations of materials using state-of-the-art electronic-structure techniques, based on density-functional theory, density-functional perturbation theory, and many-body perturbation theory, within the plane-wave pseudopotential and projector-augmented-wave approaches. Quantum EXPRESSO owes its popularity to the wide variety of properties and processes it allows to simulate, to its performance on an increasingly broad array of hardware architectures, and to a community of researchers that rely on its capabilities as a core open-source development platform to implement their ideas. In this paper we describe recent extensions and improvements, covering new methodologies and property calculators, improved parallelization, code modularization, and extended interoperability both within the distribution and with external software.
Collapse
Affiliation(s)
- P Giannozzi
- Department of Mathematics, Computer Science, and Physics, University of Udine, via delle Scienze 206, I-33100 Udine, Italy
| | - O Andreussi
- Institute of Computational Sciences, Università della Svizzera Italiana, Lugano, Switzerland
- Theory and Simulation of Materials (THEOS), and National Centre for Computational Design and Discovery of Novel Materials (MARVEL), Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland
| | - T Brumme
- Wilhelm-Ostwald-Institute of Physical and Theoretical Chemistry, Leipzig University, Linnéstr. 2, D-04103 Leipzig, Germany
| | - O Bunau
- IMPMC, UMR CNRS 7590, Sorbonne Universités-UPMC University Paris 06, MNHN, IRD, 4 Place Jussieu, F-75005 Paris, France
| | - M Buongiorno Nardelli
- Department of Physics and Department of Chemistry, University of North Texas, Denton, TX, United States of America
| | - M Calandra
- IMPMC, UMR CNRS 7590, Sorbonne Universités-UPMC University Paris 06, MNHN, IRD, 4 Place Jussieu, F-75005 Paris, France
| | - R Car
- Department of Chemistry, Princeton University, Princeton, NJ 08544, United States of America
| | - C Cavazzoni
- CINECA-Via Magnanelli 6/3, I-40033 Casalecchio di Reno, Bologna, Italy
| | - D Ceresoli
- Institute of Molecular Science and Technologies (ISTM), National Research Council (CNR), I-20133 Milano, Italy
| | - M Cococcioni
- Theory and Simulation of Materials (THEOS), and National Centre for Computational Design and Discovery of Novel Materials (MARVEL), Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland
| | - N Colonna
- Theory and Simulation of Materials (THEOS), and National Centre for Computational Design and Discovery of Novel Materials (MARVEL), Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland
| | - I Carnimeo
- Department of Mathematics, Computer Science, and Physics, University of Udine, via delle Scienze 206, I-33100 Udine, Italy
| | - A Dal Corso
- SISSA-Scuola Internazionale Superiore di Studi Avanzati, via Bonomea 265, I-34136 Trieste, Italy
- CNR-IOM DEMOCRITOS, Istituto Officina dei Materiali, Consiglio Nazionale delle Ricerche, Italy
| | - S de Gironcoli
- SISSA-Scuola Internazionale Superiore di Studi Avanzati, via Bonomea 265, I-34136 Trieste, Italy
- CNR-IOM DEMOCRITOS, Istituto Officina dei Materiali, Consiglio Nazionale delle Ricerche, Italy
| | - P Delugas
- SISSA-Scuola Internazionale Superiore di Studi Avanzati, via Bonomea 265, I-34136 Trieste, Italy
| | - R A DiStasio
- Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853, United States of America
| | - A Ferretti
- CNR Istituto Nanoscienze, I-42125 Modena, Italy
| | - A Floris
- School of Mathematics and Physics, College of Science, University of Lincoln, United Kingdom
| | - G Fratesi
- Dipartimento di Fisica, Università degli Studi di Milano, via Celoria 16, I-20133 Milano, Italy
| | - G Fugallo
- ETSF, Laboratoire des Solides Irradiés, Ecole Polytechnique, F-91128 Palaiseau cedex, France
| | - R Gebauer
- The Abdus Salam International Centre for Theoretical Physics (ICTP), Strada Costiera 11, I-34151 Trieste, Italy
| | - U Gerstmann
- Department Physik, Universität Paderborn, D-33098 Paderborn, Germany
| | - F Giustino
- Department of Materials, University of Oxford, Parks Road, Oxford OX1 3PH, United Kingdom
| | - T Gorni
- IMPMC, UMR CNRS 7590, Sorbonne Universités-UPMC University Paris 06, MNHN, IRD, 4 Place Jussieu, F-75005 Paris, France
- SISSA-Scuola Internazionale Superiore di Studi Avanzati, via Bonomea 265, I-34136 Trieste, Italy
| | - J Jia
- Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853, United States of America
| | - M Kawamura
- The Institute for Solid State Physics, Kashiwa, Japan
| | - H-Y Ko
- Department of Chemistry, Princeton University, Princeton, NJ 08544, United States of America
| | - A Kokalj
- Department of Physical and Organic Chemistry, Jožef Stefan Institute, Jamova 39, 1000 Ljubljana, Slovenia
| | - E Küçükbenli
- SISSA-Scuola Internazionale Superiore di Studi Avanzati, via Bonomea 265, I-34136 Trieste, Italy
| | - M Lazzeri
- IMPMC, UMR CNRS 7590, Sorbonne Universités-UPMC University Paris 06, MNHN, IRD, 4 Place Jussieu, F-75005 Paris, France
| | - M Marsili
- Dipartimento di Fisica e Astronomia, Università di Padova, via Marzolo 8, I-35131 Padova, Italy
| | - N Marzari
- Theory and Simulation of Materials (THEOS), and National Centre for Computational Design and Discovery of Novel Materials (MARVEL), Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland
| | - F Mauri
- Dipartimento di Fisica, Università di Roma La Sapienza, Piazzale Aldo Moro 5, I-00185 Roma, Italy
| | - N L Nguyen
- Theory and Simulation of Materials (THEOS), and National Centre for Computational Design and Discovery of Novel Materials (MARVEL), Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland
| | - H-V Nguyen
- Institute of Physics, Vietnam Academy of Science and Technology, 10 Dao Tan, Hanoi, Vietnam
| | - A Otero-de-la-Roza
- Department of Chemistry, University of British Columbia, Okanagan, Kelowna BC V1V 1V7, Canada
| | - L Paulatto
- IMPMC, UMR CNRS 7590, Sorbonne Universités-UPMC University Paris 06, MNHN, IRD, 4 Place Jussieu, F-75005 Paris, France
| | - S Poncé
- Department of Materials, University of Oxford, Parks Road, Oxford OX1 3PH, United Kingdom
| | - D Rocca
- Université de Lorraine, CRM2, UMR 7036, F-54506 Vandoeuvre-lès-Nancy, France
- CNRS, CRM2, UMR 7036, F-54506 Vandoeuvre-lès-Nancy, France
| | - R Sabatini
- Orionis Biosciences, Newton, MA 02466, United States of America
| | - B Santra
- Department of Chemistry, Princeton University, Princeton, NJ 08544, United States of America
| | - M Schlipf
- Department of Materials, University of Oxford, Parks Road, Oxford OX1 3PH, United Kingdom
| | - A P Seitsonen
- Institut für Chimie, Universität Zurich, CH-8057 Zürich, Switzerland
- Département de Chimie, École Normale Supérieure, F-75005 Paris, France
| | - A Smogunov
- SPEC, CEA, CNRS, Université Paris-Saclay, F-91191 Gif-Sur-Yvette, France
| | - I Timrov
- Theory and Simulation of Materials (THEOS), and National Centre for Computational Design and Discovery of Novel Materials (MARVEL), Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland
| | - T Thonhauser
- Department of Physics, Wake Forest University, Winston-Salem, NC 27109, United States of America
| | - P Umari
- Dipartimento di Fisica e Astronomia, Università di Padova, via Marzolo 8, I-35131 Padova, Italy
- CNR-IOM DEMOCRITOS, Istituto Officina dei Materiali, Consiglio Nazionale delle Ricerche, Italy
| | - N Vast
- Laboratoire des Solides Irradiés, École Polytechnique, CEA-DRF-IRAMIS, CNRS UMR 7642, Université Paris-Saclay, F-91120 Palaiseau, France
| | - X Wu
- Department of Physics, Temple University, Philadelphia, PA 19122-1801, United States of America
| | - S Baroni
- SISSA-Scuola Internazionale Superiore di Studi Avanzati, via Bonomea 265, I-34136 Trieste, Italy
| |
Collapse
|
42
|
Honma M, Masaoka Y, Kuroda T, Futamura A, Shiromaru A, Izumizaki M, Kawamura M. Impairment of cross-modality of vision and olfaction in Parkinson’s disease. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.988] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
43
|
Uehara H, Shirai T, Yasuda A, Kondo H, Nakayama T, Matsutani N, Kawamura M. P-232PLEURAL CARBON DIOXIDE INSUFFLATION DURING THORACOSCOPIC SURGERY HELPS TO OBTAIN CLEAR THORACOSCOPIC ULTRASONOGRAPHY IMAGES OF SMALL LUNG NODULES: REPORT OF TWO CASES. Interact Cardiovasc Thorac Surg 2017. [DOI: 10.1093/icvts/ivx280.232] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
44
|
Futamura A, Kuroda T, Shiromaru A, Honma M, Masaoka Y, Midorikawa A, Yamamoto S, Kitazawa S, Kawamura M, Ono K. The disconnecting syndromes and temporal order judgment. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.560] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
45
|
Koike N, Kawamura M, Ohno M, Sakimura K, Tanaka K. Exploring the epitopes of anti-MOG antibodies in the patients with inflammatory demyelinating disease presenting various clinical phenotypes. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.1826] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
46
|
Kikuchi R, Kawamura M. Korbinian Brodmann's scientific profile, and academic works. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.986] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
47
|
Sakai T, Uehara H, Shirai S, Kanaoka R, Nakayama T, Matsutani N, Kawamura M, Kondo H. P-242SUCCESSFUL SURGICAL REMOVAL OF A FOREIGN BODY IN THE PULMONARY ARTERY. Interact Cardiovasc Thorac Surg 2017. [DOI: 10.1093/icvts/ivx280.242] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
48
|
Fujita Y, Shinkuma S, Lee S, Nakayama C, Matsumura W, Nomura T, Kawamura M, Masutomi N, Shimizu H. 186 CL2020, a human multilineage-differentiating stress enduring cells-rich product, has a potential to treat dystrophic epidermolysis bullosa. J Invest Dermatol 2017. [DOI: 10.1016/j.jid.2017.07.183] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
49
|
Nakashima H, Tabira T, Kawamura N, Kawamura M, Kawamura Y. Effectiveness of rehabilitation on the cognitive function impairment in CVD patients. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.2160] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
50
|
Yamato G, Yamaguchi H, Handa H, Shiba N, Kawamura M, Wakita S, Inokuchi K, Hara Y, Ohki K, Okubo J, Park MJ, Sotomatsu M, Arakawa H, Hayashi Y. Clinical features and prognostic impact ofPRDM16expression in adult acute myeloid leukemia. Genes Chromosomes Cancer 2017; 56:800-809. [DOI: 10.1002/gcc.22483] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2017] [Revised: 07/10/2017] [Accepted: 07/10/2017] [Indexed: 01/22/2023] Open
Affiliation(s)
- Genki Yamato
- Department of Hematology/Oncology; Gunma Children's Medical Center; Gunma Japan
- Department of Pediatrics; Gunma University Graduate School of Medicine; Gunma Japan
| | | | - Hiroshi Handa
- Department of Hematology; Gunma University; Gunma Japan
| | - Norio Shiba
- Department of Hematology/Oncology; Gunma Children's Medical Center; Gunma Japan
- Department of Pediatrics; Yokohama City University Hospital; Kanagawa Japan
| | | | - Satoshi Wakita
- Department of Hematology; Nippon Medical School; Tokyo Japan
| | - Koiti Inokuchi
- Department of Hematology; Nippon Medical School; Tokyo Japan
| | - Yusuke Hara
- Department of Hematology/Oncology; Gunma Children's Medical Center; Gunma Japan
- Department of Pediatrics; Gunma University Graduate School of Medicine; Gunma Japan
| | - Kentaro Ohki
- Department of Hematology/Oncology; Gunma Children's Medical Center; Gunma Japan
- Department of Pediatric Hematology and Oncology Research; National Research institute for Child Health and Development; Tokyo Japan
| | - Jun Okubo
- Department of Hematology/Oncology; Gunma Children's Medical Center; Gunma Japan
| | - Myoung-Ja Park
- Department of Hematology/Oncology; Gunma Children's Medical Center; Gunma Japan
| | - Manabu Sotomatsu
- Department of Hematology/Oncology; Gunma Children's Medical Center; Gunma Japan
| | - Hirokazu Arakawa
- Department of Pediatrics; Gunma University Graduate School of Medicine; Gunma Japan
| | - Yasuhide Hayashi
- Department of Hematology/Oncology; Gunma Children's Medical Center; Gunma Japan
- Director General, Japanese Red Cross Gunma Blood Center; Gunma Japan
| |
Collapse
|